医学
疾病
临床试验
重症监护医学
危险分层
炎症性肠病
生物信息学
病理
内科学
生物
作者
Zsuzsanna H. McMahan,John E. Pandolfino,Harris Perlman,Francesco Del Galdo,Monique Hinchcliff
标识
DOI:10.1097/bor.0000000000001052
摘要
Identifying outcomes and clinical trial endpoints enabled the discovery of new inflammatory bowel disease (IBD) treatments. Herein, we describe efforts to advance the study of gastrointestinal (GI) manifestations in systemic sclerosis (SSc).
科研通智能强力驱动
Strongly Powered by AbleSci AI